Canada markets closed

AnaptysBio, Inc. (ANAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.23+0.16 (+0.64%)
As of 09:55AM EDT. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-163,300
-163,619
-128,724
-57,796
-19,931
Depreciation & amortization
2,388
2,376
2,335
2,090
1,617
Stock based compensation
34,476
33,205
27,356
15,347
11,499
Change in working capital
-15,815
-324
6,839
-7,489
-7,829
Accounts receivable
-5,566
-5,432
-543
-876
0
Accounts Payable
-2,767
10,938
9,700
-4,740
-7,694
Other working capital
-134,144
-121,607
-73,951
-47,286
-14,726
Other non-cash items
676
18,083
21,108
1,450
-
Net cash provided by operating activites
-133,485
-120,800
-73,593
-45,920
-14,157
Cash flows from investing activities
Investments in property, plant and equipment
-659
-807
-358
-1,366
-569
Purchases of investments
-314,361
-303,919
-802,503
-118,662
-194,927
Sales/Maturities of investments
442,994
449,480
408,016
158,848
289,971
Net cash used for investing activites
127,974
144,754
-394,845
38,835
94,475
Cash flows from financing activities
Debt repayment
-
-
0
0
-1,375
Common stock issued
2,018
2,472
11,827
2,553
496
Common stock repurchased
-12,474
-50,000
0
0
-
Other financing activites
-17,396
-11,769
32,190
249,745
-
Net cash used privided by (used for) financing activities
-35,356
-59,297
44,017
252,298
-879
Net change in cash
-40,867
-35,343
-424,421
245,213
79,439
Cash at beginning of period
94,562
71,308
495,729
250,516
171,077
Cash at end of period
53,695
35,965
71,308
495,729
250,516
Free Cash Flow
Operating Cash Flow
-133,485
-120,800
-73,593
-45,920
-14,157
Capital Expenditure
-659
-807
-358
-1,366
-569
Free Cash Flow
-134,144
-121,607
-73,951
-47,286
-14,726